These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26376691)

  • 1. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Stamer U; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2018 May; 22(5):973-988. PubMed ID: 29363217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial.
    Schliessbach J; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Vuilleumier PH; Stamer U; Arendt-Nielsen L; Curatolo M
    PLoS One; 2018; 13(5):e0195776. PubMed ID: 29742109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain.
    Schliessbach J; Vuilleumier PH; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2017 Sep; 21(8):1336-1345. PubMed ID: 28418172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain.
    Lee JH; Lee CS;
    Clin Ther; 2013 Nov; 35(11):1830-40. PubMed ID: 24183364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
    Webster LR; Butera PG; Moran LV; Wu N; Burns LH; Friedmann N
    J Pain; 2006 Dec; 7(12):937-46. PubMed ID: 17157780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: a crossover, randomised, double-blinded, placebo-controlled study.
    Wetzel L; Zadrazil M; Paternostro-Sluga T; Authried G; Kozek-Langenecker S; Scharbert G
    Eur J Anaesthesiol; 2014 Jan; 31(1):35-40. PubMed ID: 24141646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects.
    Eisenberg E; Midbari A; Haddad M; Pud D
    Pain; 2010 Oct; 151(1):104-109. PubMed ID: 20621419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
    Rauck RL; Nalamachu S; Wild JE; Walker GS; Robinson CY; Davis CS; Farr SJ
    Pain Med; 2014 Jun; 15(6):975-85. PubMed ID: 24517082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is low-dose amitriptyline effective in the management of chronic low back pain? Study protocol for a randomised controlled trial.
    Urquhart DM; Wluka AE; Sim MR; van Tulder M; Forbes A; Gibson SJ; Arnold C; Fong C; Anthony SN; Cicuttini FM
    Trials; 2016 Oct; 17(1):514. PubMed ID: 27770809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost-effectiveness of intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial.
    Geurts JW; Kallewaard JW; Kessels A; Willems PC; van Santbrink H; Dirksen C; van Kleef M
    Trials; 2015 Nov; 16():532. PubMed ID: 26590962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
    Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
    Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study.
    Uberall MA; Mueller-Schwefe GH; Terhaag B
    Curr Med Res Opin; 2012 Oct; 28(10):1617-34. PubMed ID: 22970658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain.
    de la Iglesia FA; Pace GW; Robinson GL; Huang NY; Stern W; Richards P
    J Opioid Manag; 2012; 8(2):89-98. PubMed ID: 22616314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.